Document:

Exhibit 10.51 123106

    Exhibit
      10.51

    EMLOYMENT
      CONTRACT

    

    This
      Employment Contract (“Contract”) is entered into by and between Amarillo
      Biosciences, Inc., a Texas corporation (“Employer”) and Martin J. Cummins
      (“Employee”). ABI and its controlled subsidiaries shall be hereinafter
      collectively referred to as “ABI Companies”. Employer hereby employs Employee,
      and Employee accepts employment, on the following terms and
      conditions.

    

    ARTICLE
      I

    TERM
      OF EMPLOYMENT

    

    1.01.
      By this
      Contract, Employer employs Employee, and Employee accepts employment with
      Employer starting September 10, 2006, and with such ABI Companies as Employer
      shall designate, until this Contract shall have been terminated by either party
      by the serving of three months’ advance, written notice of such termination upon
      the other party.

    

    ARTICLE
      II

    COMPENSATION

    

    2.01.
      As
      compensation for all services rendered under this Contract, Employee shall
      be
      paid by Employer a salary of ONE HUNDRED TWENTY FIVE THOUSAND DOLLARS
      ($125,000.00) per year, payable at least monthly during the term of this
      Contract. The amount paid is to be prorated for any partial employment period.
      Furthermore, Employee recognizes that Employer may experience periodic cash
      shortages, and in such event, Employee will accept partial (no more than 50%)
      payment in Employer’s voting common stock, which stock shall be registered by
      Employer on Form S-8, or other suitable registration statement.

    

    ARTICLE
      III

    DUTIES
      OF EMPLOYEE

    

    3.01.
      Employee
      is employed as Director of Clinical and Regulatory Affairs of Employer, and
      shall work at the corporate offices in Amarillo, Texas. Employee shall perform
      the duties of as Director of Clinical and Regulatory Affairs, as such duties
      may
      be further set fourth in the Bylaws of Employer, or by resolution of the Board
      of Directors of Employer. Employee shall devote his entire productive time,
      ability, attention and energies to the business of Employer during the term
      of
      this Contract, and during such time, Employee shall not directly or indirectly
      render any services of a business, commercial or professional nature to any
      other person or organization, whether or not for compensation, without the
      prior
      consent of the Board of Directors of Employer. Consent is hereby granted to
      Employee to continue an ongoing project called Orange County Lipworks, LLC
      with
      his brother Matthew.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    ARTICLE
      IV

    EMPLOYEE’S
      OBLIGATIONS AS TO INSURANCE

    

    4.01.
      Employee
      agrees to submit to physical examination as may be required for the obtaining
      by
      Employer of insurance on Employee’s life, and agrees to consent to the issuance
      of a policy or policies of insurance on his life, such policies to be owned
      by
      Employer, and naming Employer as beneficiary. Upon termination of Employee’s
      employment for any reason, and if requested by Employee, Employer shall assign
      any such policy to Employee, so that Employee shall have the option of keeping
      the policy in force at Employee’s expense. The forgoing notwithstanding,
      Employer shall be entitled to retain the accumulated cash value of any such
      policy.

    

    ARTICLE
      V

    EMPLOYEE
      BENEFITS

    

    5.01.
      If
      Employer provides hospital, surgical, medical, dental, group life insurance,
      or
      other fringe benefits to its employees, or any of them, at any time during
      the
      term of this Contract, Employee shall be entitled to participate in such
      benefits, on terms and conditions at least as favorable as those accorded to
      other employees of Employer, subject to insurability. 

    

    ARTICLE
      VI

    REIMBURSEMENT
      OF EXPENSES INCURRED BY EMPLOYEE

    

    6.01.
      Employee
      is authorized to incur reasonable business expenses for promoting the business
      of Employer, including expenditures for entertainment and travel. Employer
      will
      reimburse Employee for all such expenses upon Employee’s presentation of written
      expense vouchers, itemizing such expenditures.

    

    ARTICLE
      VII

    PROPERTY
      RIGHTS OF PARTIES

    

    7.01.
      Employee
      has had access to and become familiar with, and during the term of continued
      employment, will continue to have access to and become familiar with, various
      trade secrets, consisting of formulas, devices, secret inventions, processes,
      compilations of information, records, and specifications owned by ABI Companies
      and regularly used in the operation of ABI Companies. Employee shall not
      disclose any such trade secrets directly or indirectly nor use them in any
      way
      either during the term of this Contract or at any time thereafter except as
      required in the course of his employment. All files, records, documents,
      drawings, specifications, equipment and similar items relation to the business
      of ABI Companies, whether or not prepared by Employee, shall remain the
      exclusive property of ABI Companies and shall not be removed from the premises
      of Employer under any circumstances, except in pursuit of the trade and business
      of ABI Companies.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    7.02.
      On the
      termination of employment or whenever requested by Employer, Employee shall
      immediately deliver to Employer all property in Employee’s possession or under
      Employee’s control belonging to ABI Companies, including but not limited to all
      accounting records, computer terminals and tapes, disks, or other data storage
      mechanisms, accounting machines, and all office furniture and fixtures, supplies
      and other personal property in the possession or under the control of Employee,
      in good condition, ordinary wear and tear excepted, and including without
      limitation all correspondence files, research data, and patent information
      or
      data, of every sort.

    

    7.03.  Employee
      hereby promises and agrees to convey and assign to Employer any and all other
      rights or interests he may now have in and to trade secrets, formulas, devices,
      inventions, processes, patents, applica-tions, continuations, copyrights,
      trademarks, compilations of information, records, specifications, rights,
      interests and data of every other sort, affecting or pertaining directly or
      indirectly to the business of ABI Companies as now conducted, or to the patents,
      trade secrets, and other rights not owned by ABI Companies. In further
      clarification of the preceding sentence, it is not Employee's intention to
      retain individual-ly any such rights or interests. Employee does not claim
      any
      rights or interests in and to trade secrets, formulas, devices, inventions,
      processes, patents, applications, continuations, copyrights, trade-marks,
      compilations of information, records, specifications, rights, interests and
      data
      of any other sort, affecting or pertaining directly or indirectly to the
      business of ABI Companies as now conducted, or to the patents, trade secrets,
      and other rights now owned by ABI Companies.

    

    7.04. Employee
      agrees that he will promptly and fully inform and disclose to Employer all
      inventions, designs, improvements and discoveries that Employee may have during
      the term of this Contract that pertain or relate to the business of ABI
      Companies or to any experimental work carried on by ABI Companies, whether
      conceived by Employee alone or with others and whether or not conceived during
      regular working hours. All such inventions, designs, improvements and
      discoveries shall be the exclusive property of Employer. Employee shall assist
      ABI Companies in obtaining patents on all such inven-tions, designs,
      improvements and discoveries deemed patentable by ABI Companies, and shall
      execute all documents and do all things necessary to obtain such patents for
      Employer or ABI Companies.

    

    7.05.
      It is
      contemplated that Employee in the course of his employment will be engaged
      in
      work involving various patents and secret processed owned by ABI Companies.
      All
      experiments, developments, formulas, patterns, devices, secret inventions and
      compilations of information, records and specifications regarding such matter
      are trade secrets, which Employee shall not disclose directly or indirectly
      to
      anyone other than ABI Companies or their agents, or use in any way either during
      the term of this Contract or at any time after the termination of this Contract,
      except as required in the course and scope of his employment.

    

    7.06.
      During
      the term of this Contract, Employee shall not directly or indirectly either
      as
      an employee, employer, consultant, agent, principal, partner, stock holder,
      

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    corporate
      office, director, or in any other individual or representative capacity engage
      or participate in any business that is in competition in any manner whatsoever
      with the business of ABI Companies; provided, however, that Employee may without
      restriction invest in professionally managed mutual funds and Employee may
      purchase, own and sell stock or other securities, as long as Employee is not
      directly or indirectly through one or more intermediaries in control of or
      controlled by or under common control with any such company. Furthermore, upon
      the termination of this Contract, Employee expressly agrees not to engage or
      participate directly or indirectly in any business that is in competition with
      the business of ABI Companies, for a period of three (3) years; and further
      provided, that no business will be considered to be in competition with ABI
      Companies unless its business relates to the manufacture, sale, testing or
      development of products containing alpha
      interferon.
      Employer and Employee recognize and agree that ABI Companies may obtain or
      develop additional technologies from time to time, and if that is the case,
      Employer may expand the terms of this non-competition provision by giving
      written notice to Employee of the additional technologies that are to be
      protected.

    

    7.07.
      In the
      event of a breach of Employee of any provisions of this Article VII, the parties
      hereto agree that Employer, in addition to any other remedies to which Employer
      may be entitled at law, shall be entitled to the remedy of specific performance,
      it being understood and agreed by the parties hereto that damages may be
      difficult to ascertain, and that an award of damages would in all probability
      not sufficiently compensate Employer for any breach of Employee of such
      provisions. ABI Companies are intended third-party beneficiaries of the
      provisions of this Article VII.

    

    ARTICLE
      VIII

    STOCK
      OPTION

    

    8.01.
      Employer
      hereby grants to Employee non-transferable stock options to purchase 400,000
      shares of Employer’s voting common stock, subject to the terms and conditions
      hereinafter set forth in this Article VIII. Where required by applicable laws
      or
      regulation, or by administrative necessity, the Board of Directors of Employer
      may prescribe additional terms and conditions regarding the issuance and
      administration of the stock option, as long as such additional terms and
      conditions do not conflict with the terms and conditions hereinafter set
      forth.

    

    8.02.
      The
      options granted pursuant to Section 8.01 above, shall be exercisable as
      follows:

    

    
      	 	
              a. 
                

            	
              as
                to 100,000 shares, between September 10, 2007 and September 9, 2012,
                inclusive; 

            

    

    

    
      	 	
              b. 
                

            	
              as
                to 100,000 shares, between September 10, 2008 and September 9, 2013,
                inclusive; and

            

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    	c. 	
            as
              to 100,000 shares, between September 10, 2009 and September 9, 2014,
              inclusive; and

          

    

    	d. 	
            as
              to 100,000 shares, between September 10, 2010 and September 9, 2015,
              inclusive.

          

    

    The
      exercise price for all options shall be the closing price of ABI stock on
      September 8, 2006.

    

    The
      foregoing notwithstanding, no options which are not already theretofore
      exercisable shall become exercisable at any time after the termination of
      Employee’s full time active employment with Employer.

    

    8.03.
      In the
      event of death or complete disability of Employee, or a voluntary termination
      of
      employment (which shall include the resignation of Employee, or the giving
      of a
      notice of termination of this Contract, or a successor or amended employment
      contract, by Employee pursuant to Section 1.01, above), Employee (or if
      applicable, Employee’s estate or personal representative) shall have a period of
      sixty (60) days within which to exercise any matured (exercisable) options
      which
      have not theretofore been exercised; and after the expiration of said sixty
      (60)
      day period, such options shall expire and be of no further force or effect.
      In
      the event of notice of a pending or completed Change in Control, as hereinafter
      defined, all options held by Employee under this Employment Contract shall
      be
      immediately exercisable, and Employee shall thereupon have a period of sixty
      (60) days within which to exercise any or all of such options; and after the
      expiration of said sixty (60) day period, such options shall expire and be
      of no
      further force or effect. 

    

    For
      purposes of this Agreement, “Change in Control” shall mean when any entity,
      person or group other than Employer or a Subsidiary of Employer or Hayashibara
      Biochemical Laboratories, Inc. or an affiliate thereof acquires shares of
      Employer in a transaction or series of transactions that result in such entity,
      person or group directly or indirectly owning beneficially fifty-one percent
      (51%) or more of Employer’s outstanding shares of voting common
      stock.

    

    8.04.
      Stock for Stock Exercise.
      Where
      Employee so elects by written notification to Employer prior to or
      simultaneously with the exercise of one or more options, the exercise may be
      accomplished on a “stock for stock” basis as follows: in lieu of payment to
      Employer of the cash exercise price with respect to the options exercised,
      there
      shall be calculated the number of shares that could be purchased for the cash
      exercise price; and that number of shares shall be deducted from the shares
      issuable to Employee, with respect to that option exercise. 

    

    8.05.
      The
      stock
      options herein granted are not qualified or incentive stock options within
      the
      meaning of the Internal Revenue Code of 1986, or successor provisions. Employer
      has provided no tax advice to Employee with respect to the taxation of the
      

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    grant
      and/or exercise of such options, and/or the disposition of the underlying
      shares, and Employee has been advised to consult with his own tax advisor
      regarding such matters. Furthermore, the underlying shares will not be
      registered with the SEC, and will therefore be “Restricted Securities” within
      the meaning of Rule 144, promulgated under the Securities Act of 1933. Employer
      cannot insure that its securities will continue to qualify for sale or resale
      under Rule 144, and in the event Rule 144 should at some time be no longer
      available with regard to such sales, Employee might find it difficult or
      impossible to sell the option shares.

    

    ARTICLE
      IX

    ENTIRETY
      OF AGREEMENT; AMENDMENTS; SURVIVAL

    

    9.01.
      This
      Contract supersedes all other agreements, either oral or in writing, between
      the
      parties to this Contract with respect to the employment of Employee by Employer.
      This Contract contains the entire understanding of the parties and all of the
      covenants and agreements between the parties with respect to such
      employment.

    

    9.02.
      This
      Contract may be amended only by an instrument signed in writing by both parties;
      and provided further, that no amendment may be executed on behalf of Employer,
      except pursuant to a resolution of the Board of Director of
      Employer.

    

    9.03.
      The
      following provisions shall survive the expiration of this Agreement: ARTICLES
      VII, VIII, and IX.

    

    IN
      WITNESS WHEREOF, this Contract is executed by the undersigned as of this 10th
      day of October, 2006.

    

    
      	
              EMPLOYEE:

            	 	
              EMPLOYER:

            
	 	 	
              AMARILLO
                BIOSCIENCES, INC.

            
	 	 	 
	
              /s/
                Martin J. Cummins

            	 	
              /s/
                Joseph M. Cummins

            
	
              Martin
                J. Cummins

            	 	
              Joseph
                M. CumminsExhibit 10.52 123106

    Exhibit
      10.52

    SUPPLY
      AGREEMENT

    ANHYDROUS
      CRYSTALLINE MALTOSE

    

    THIS
      AGREEMENT is made and effective this 26th day of October, 2006, by and between
      AMARILLO BIOSCIENCES, INC., a Texas corporation with its principal place of
      business at 4134 Business Park Drive, Amarillo, Texas 79110 (hereinafter “ABI”)
      and HAYASHIBARA BIOCHEMICAL LABORATORIES, INC. and HAYASHIBARA SHOJI, INC.,
      each
      of them with its principal place of business at 2-3, Shimoishii 1-chome, Okayama
      700-0907, Japan (hereinafter collectively “Hayashibara”). ABI and Hayashibara
      collectively referred to hereinafter as the “Parties”.

     

    WHEREAS,
      Hayashibara desires to grant to ABI, and ABI desires to have, the exclusive
      right to purchase and distribute Hayashibara’s pharmaceutical grade anhydrous
      crystalline maltose, subject to the specifications as attached herewith
      (hereinafter “ACM”), for sale as an active ingredient in a nutraceutical product
      to treat dry mouth, which are developed, produced and commercialized by ABI's
      proprietary technology worldwide, except Japan.

     

    NOW,
      THEREFORE, for and in consideration of the mutual covenants contained herein,
      Hayashibara and ABI agree as follows:

     

    Section
      1. Right to Purchase and Distribute Exclusively for Dry
      Mouth.

     

    Hayashibara
      hereby grants to ABI the exclusive right to purchase, distribute and sell,
      worldwide, except Japan, a nutraceutical product for human consumption
      containing ACM as an active ingredient to relieve dry mouth (hereinafter the
      “Products”).

     

    Section
      2. Consideration.

     

    Hayashibara
      shall receive a transfer fee from ABI in the amount of **** per kilogram. f.o.b.
      Kobe, Japan. At any time after the second contract year, either Party may notify
      the other that it desires to renegotiate the transfer fee. In such case, the
      parties shall attempt, in good faith, to agree to a mutually acceptable transfer
      fee. In the event the Parties agree to a modified transfer fee, said modified
      fee shall remain in force for a minimum of Two (2) years, and if the term of
      this Agreement is then within Two (2) years of expiration, the term of this
      Agreement shall be extended so that this Agreement shall terminate Two (2)
      years
      from the date the modified transfer fee became effective. In the event the
      Parties fail to agree to a modified transfer fee, either Party may terminate
      this Agreement by giving Six (6) months advanced written notice to the other
      party.

     

    Section
      3. Term.

     

    Unless
      sooner terminated as hereinafter provided, this Agreement shall remain in effect
      for a period of Five (5) years from the date of this Agreement. After that
      initial term, the Agreement shall be automatically renewed for successive One
      (1) year term unless one of the Parties gives written notice of termination
      or
      modification of this Agreement to the other 

     

    
      
        ****
          Indicates that a portion of the text has been omitted and filed separately
          with
          the Commission

        CONFIDENTIAL

        
        

      

      
        1

        
          

        

      

      
        
        

      

    

    within
      Thirty (30) days prior to commencement of the renewal term. Any termination
      pursuant to this paragraph shall not relieve Hayashibara of any obligation
      to
      fill purchase orders placed with Hayashibara prior to termination. Similarly,
      such termination shall not relieve ABI of any obligation to Hayashibara to
      pay
      for ACM delivered by Hayashibara and any payment due hereunder prior to tell
      termination.

     

    If
      ABI
      shall at any time during the initial term or any subsequent renewal term of
      this
      Agreement default in any obligation hereunder or fail to pay any payment due,
      and such default shall not be cured within sixty (60) days after written notice
      from Hayashibara to ABI specifying the nature of the default, Hayashibara may
      terminate this Agreement, or may demand specific performance and remedies for
      violation of the terms of this Agreement under applicable law.

     

    If
      ABI
      shall be involved in financial difficulties as evidenced (a) by its commencement
      of a voluntary bankruptcy under any applicable bankruptcy code or statute,
      or by
      its authorizing, by appropriate proceedings, the commencement of such a
      voluntary bankruptcy; or (b) by its failing to receive dismissal of any
      involuntary case under any applicable bankruptcy code or statute within Sixty
      (60) days after initiation of such action or petition; or (c) by its seeking
      relief as a debtor under any applicable law of any jurisdiction relating to
      the
      liquidation or reorganization of debtors or to the modification or alteration
      of
      the rights of creditors, or by consenting to or acquiescing in such relief,
      or
      (d) by the entry of an order by a court of competent jurisdiction finding it
      to
      be bankrupt or insolvent, or ordering or approving its liquidation,
      reorganization or any modification or alteration of the rights of its creditors
      or assuming custody of, or appointing a receiver or other custodian for, all
      or
      a substantial part of its property or assets; or (e) by its making an assignment
      for the benefit of, or entering into a composition with, its creditors, or
      appointing or consenting to the appointment of a receiver or other custodian
      for
      all or a substantial part of its property, this Agreement shall be terminated
      immediately.

     

    Section
      4. Orders, Shipment and Payment.

     

    Actual
      quantities and delivery dates relating to ACM shall be specified in purchase
      orders submitted by ABI to Hayashibara, which purchase orders shall constitute
      firm and legally binding orders. Unless otherwise agreed in writing, Hayashibara
      hereunder shall accept each "individual purchase order by notifying ABI in
      writing its acceptance of an order within Ten (10) business days of receipt
      of
      the purchase order. Hayashibara shall ship ACM as specified in such accepted
      purchase orders within Thirty (30) days after Hayashibara's acceptance of a
      purchase order from ABI. The shipment of ACM under this Agreement shall be
      made
      on f.o.b. Kobe, Japan, unless otherwise agreed in writing. For shipment of
      ACM
      Hayashibara may arrange for a vessel or vessel space in ABI's name at ABI's
      cost.

     

    Section
      5. Minimum Purchase.

     

    For
      the
      second contract year (which shall be the Twelve (12) month period commencing
      after the expiration of One (1) year from the date of this Agreement), ABI
      guarantees that it will purchase at least **** of ACM, with such amount
      increasing to **** for the third contract year, **** for the fourth contract
      year, and **** for the fifth and subsequent contract years.

     

    
      
        ****
          Indicates that a portion of the text has been omitted and filed separately
          with
          the Commission

        CONFIDENTIAL

        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    

     

    ABI
      agrees that the complete performance of the above minimum purchase guarantee
      is
      of essence for assuring the maintenance and continuation of this Agreement
      as an
      exclusive Supply Agreement. In the event such minimum purchases are not
      effected, this Agreement shall become nonexclusive; provided, however, that
      if
      the Parties shall have renegotiated an increased transfer fee pursuant to
      Section 2, above, and this Agreement thereafter becomes non-exclusive,
      Hayashibara shall not sell ACM to another party at a price less than the latest
      renegotiated transfer fee pursuant to Section 2, above.

     

    Section
      6. Indemnification.

     

    ABI
      shall
      indemnify, hold harmless and defend Hayashibara from all claims, demands,
      payments, suits, actions and judgments brought, recovered or executed against
      the Parties on account of death, injury or damage sustained by any party in
      connection with ABI's distribution, marketing or sales of the Products under
      this Agreement, to the extent that such claims are the result of actions or
      inactions by ABI or its affiliates acting hereunder pursuant to this
      Section.

     

    Hayashibara
      shall indemnify, hold harmless and defend ABI from all claims, demands,
      payments, suits, actions and judgments brought, recovered or executed against
      the Parties on account of death, injury or damage sustained by any party in
      connection with Hayashibara's manufacture or shipment of ACM under this
      Agreement, to the extent that such claims are the result of actions or inactions
      by Hayashibara.

     

    Section
      7. Confidentiality.

     

    Each
      of
      the Parties agrees to maintain confidential and secret all information which
      may
      be disclosed or provided to it by the other and that the Parties may together
      subsequently acquire in relation to the Products and which is designated in
      writing by clearly identifiable legend as being confidential or secret in
      character.

     

    Each
      Party's obligation to the other (to maintain confidentiality) hereunder shall
      terminate with respect to any particular item and only said item of the
      disclosing Party's confidential information, when the recipient Party can
      demonstrate that such item of information:

     

    (1)
      Is
      publicly known and available through some means other than by the recipient
      Party's act or omission; or 

     

    (2)
      Was
      in the recipient Party's possession prior to its disclosure by the other Party,
      provided that written evidence of such possession is established;
      or

     

    (3)
      Has
      come into the recipient Party's possession through a third party free of any
      obligation of confidentiality to the disclosing Party, where said third party
      has acquired information lawfully and not under circumstances forbidding its
      disclosure. 

     

    
      
        ****
          Indicates that a portion of the text has been omitted and filed separately
          with
          the Commission

        CONFIDENTIAL

        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    

     

    Neither
      Party will permit confidential or secret information nor any part thereof to
      be
      disclosed to third parties or to employees except on a “need-to-know” basis and
      each will maintain confidential or secret information and/or documents with
      the
      same precautions it uses to safeguard its own confidential or secret
      information.

     

    Each
      Party will notify the other promptly if it has knowledge that a third party
      possesses confidential or secret information of the other Party related to
      the
      Products.

     

    Section
      8. Miscellaneous.

     

    (1)
      Force
      Majeure.

     

    The
      failure of Hayashibara, ABI, or any of their affiliates or sublicenses to take
      any act required by this Agreement if occasioned by an act of God or the public
      enemy, fire, explosion, perils of the sea, floods, drought, war, riot, sabotage,
      accident, embargo or any circumstances of like or different character beyond
      the
      reasonable control of the Party so failing or by the interruption or delay
      in
      transportation, inadequacy, or shortage or failure of the supply of materials
      and/or request of any governmental officer, department or agency and whether
      in
      any case such circumstance now exists or hereafter arises, shall not subject
      said Party to any liability to the other.

     

    (2)
      Arbitration.

     

    The
      Parties hereto desire to avoid and settle without litigation future disputes
      that may arise between them relative to this Agreement. Accordingly, the parties
      agree to engage in good faith negotiations to resolve any such dispute. In
      the
      event they are unable to resolve any such dispute by negotiation, such dispute
      shall be submitted to arbitration as follows: If arbitration is initiated by
      Hayashibara, it shall be held in the State of Texas, USA, in compliance with
      the
      Commercial Arbitration Rules of the American Arbitration Association. If
      arbitration is initiated by ABI, it shall be held in Tokyo, Japan in compliance
      with the Rules of the Japan Commercial Arbitration Association. The arbitration
      award shall be final and binding upon the parties hereto and may be filed with
      and enforced by any competent court having jurisdiction to enforce said
      award.

     

    (3)
      Communication.

     

    Any
      payment, notice or other communication required or permitted to be made or
      given
      to either Party hereto pursuant to this Agreement shall be sufficiently made
      or
      given on the date of sending if sent to such Party by certified or registered
      mail or by Federal Express or a similar overnight courier service, postage
      or
      delivery charge prepaid, by telex, or telephone facsimile addressed to it at
      its
      address set forth, or to such other address(es) as it may designate by written
      notice given to the other Party as follows:

     

    
      
        ****
          Indicates that a portion of the text has been omitted and filed separately
          with
          the Commission

        CONFIDENTIAL

        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    In
      case
      of HBL

     

    Dr.
      Kunihiro Ohashi 

    Overseas
      Business Development

    Hayashibara
      Company Ltd.

    2-3
      Shimoishii 1-chome

    Okayama,
      Japan

     

    In
      case
      of ABI

     

    Dr.
      Joseph M. Cummins, President

    Amarillo
      Biosciences, Inc.

    4134
      Business Park Drive

    Amarillo,
      TX 79110 

     

    (4)
      Assignment or Sublicense.

     

    This
      Agreement shall not be assignable by ABI to any person or entity without prior
      written consent of HBL, which consent shall not be unreasonably withheld in
      any
      case involving or the sale or transfer of all or substantially all of the
      business or assets of ABI. 

     

    The
      foregoing restrictions on assignment notwithstanding, ABI may contract, license,
      or otherwise employ one or more distributors to assist it in the sale of the
      Products.

     

    (5)
      Amendment.

     

    This
      Agreement shall not be amended, in whole or in part, without the prior written
      consent of the Parties.

     

    (6)
      Nature of Relationship.

     

    Nothing
      herein shall be construed to place the Parties in a relationship of partners
      or
      joint ventures, nor does this Agreement make either Party the agent or legal
      representative of the other for any purposes whatsoever. The Parties further
      agree that no representation shall be made by either Party that would create
      an
      apparent agency, employment, partnership or joint venture. Neither Party shall
      have the power express or implied, to obligate the other in any manner
      whatsoever.

     

    
      
        ****
          Indicates that a portion of the text has been omitted and filed separately
          with
          the Commission

        CONFIDENTIAL

        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    

     

    IN
      WITNESS WHEREOF, the Parties hereunto have caused this Distribution Agreement
      to
      be executed in duplicate by their duly authorized representatives as of the
      date
      first above written. 

     

    
      	
              ABI

               

            	 	
              On
                behalf of Hayashibara

               

            
	
              AMARILLO
                BIOSCIENCES, INC.

               

            	 	
              HAYASHIBARA
                BIOCHEMICAL LABORATORIES, INC.

               

            
	
              By:
                /s/ Joseph M. Cummins 

               

            	 	
              By:
                /s/ Yasushi Hayashibara 

               

            
	
              Joseph
                M. Cummins, DVM, PhD

               

            	 	
              Mr.
                Yasushi Hayashibara

              CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00120-of-00352.parquet"}]]